Science & Insights
Explore scientific publications, mechanistic safety perspectives, real-world applications, and the latest developments from Cytocast.
Discover how AI, systems biology, and mechanistic simulation are shaping earlier and more interpretable drug safety decisions.
Blog Post Cytocast announced the market entry of three leading-edge products today: Cytocast Screener™, Cytocast Optimizer™, and Cytocast Nominator™ - designed to bring earlier, more interpretable safety insights to drug discovery and preclinical decision-making.
Blog Post Using AI and whole-cell simulations, our team at Cytocast is building the next generation of drug discovery tools. The CYTOCAST DIGITAL TWIN Platform™ creates realistic, dynamic models of human cells, capable of simulating billions of molecular interactions per second.
Blog Post A recent study sheds light on the complex molecular and cellular mechanisms underpinning neurological pathologies caused by COVID-19, with a focus on microglial dysfunction and central nervous system (CNS) inflammation.
Blog Post Technological advancements are reshaping healthcare, biology, and the pharmaceutical industry, yet the terms TechBio, BioTech, and DeepTech are often used interchangeably.
Blog Post Proteins rarely function in isolation. Interactions between thousands of proteins shape a cell’s PPI network, forming transient or stable complexes.
Blog Post The process of narrowing down viable drug candidates can take years, costing millions along the way. With the Cytocast Digital Twin Patient, however, researchers can now conduct these trials in silico in a fraction of the time.
Blog Post Cytocast’s dedication to science-driven solutions reflects a significant shift in the healthcare landscape, where computational modeling and simulations are becoming indispensable tools in the quest for faster, safer, and more effective medical treatments
Blog Post Cytocast has made significant strides during the second quarter of 2024, advancing its cutting-edge technology in the field of digital twin simulations and predictive algorithms.
Blog Post Cytocast, at the forefront of innovation, utilizes AI in the Cytocast Simulated Cell to model drug-target interactions, predict efficacy, and identify potential side effects early in drug development. Our commitment extends to ethical considerations, ensuring responsible AI use in shaping the future of drug discovery.